Clinical Trial Update: Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Ingavirin for treating influenza and acute respiratory viral infections in children aged 7-12 has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold
• Respiratory Infection

Drugs mentioned

• Ingavirin

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Influenza, Human, Acute Respiratory Infection | Phase 3 | Status: COMPLETED